Announced Fri, 26 Sept · 19:30 IST

Voting Results and Scrutinizer''s Report of 52nd Annual General Meeting.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aspira Pathlab & Diagnostics held its 52nd AGM on September 26, 2025, via video conferencing. Four resolutions were put to vote, and all were passed with 100% approval from shareholders. Resolution 1 covered adoption of audited financial statements for FY ending March 31, 2025; Resolution 2 was the re-appointment of Mr. Nikunj V. Mange as Director (retiring by rotation); Resolution 3 was the appointment of Nilesh A. Pradhan & Co., LLP as Secretarial Auditors for a 5-year term. A total of 1,244,436 valid votes were cast, with 16 members voting via remote e-voting and 4 during the AGM, and zero votes against any resolution. Ms. Prajakta Padhye of Nilesh A. Pradhan & Co., LLP served as the Scrutinizer.

Likely market impact

This is a routine compliance filing confirming that all AGM resolutions were passed unanimously, with no contested items. No material impact on shareholders or stock price is expected — it's standard post-AGM disclosure.